PNC Financial Services Group
PDSB icon

PNC Financial Services Group’s PDS Biotechnology PDSB Stock Holding History

PNC Financial Services Group’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8
Closed -$32 – 4881
2024
Q1 		$32 Hold
8
– – ﹤0.01% 4669
2023
Q4 		$40 Buy
+8
New +$40 ﹤0.01% 4580
2022
Q1 		– Sell
-1,000
Closed -$8K – 4659
2021
Q4 		$8K Buy
+1,000
New +$10.8K ﹤0.01% 3854
2020
Q3 		– Sell
-300
Closed -$1K – 4011
2020
Q2 		$1K Hold
300
– – ﹤0.01% 3859
2020
Q1 		$0 Hold
300
– – ﹤0.01% 4019
2019
Q4 		$1K Hold
300
– – ﹤0.01% 3901
2019
Q3 		$1K Hold
300
– – ﹤0.01% 3934
2019
Q2 		$2K Hold
300
– – ﹤0.01% 3877
2019
Q1 		$2K Hold
300
– – ﹤0.01% 3886
2018
Q4 		$2K Hold
300
– – ﹤0.01% 3870
2018
Q3 		$5K Hold
300
– – ﹤0.01% 3824
2018
Q2 		$6K Buy
+300
New +$6.26K ﹤0.01% 3805

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group's PDSB Position: Q2 2024 in Review

PNC Financial Services Group sold out of PDS Biotechnology (PDSB) in Q2 2024, closing a stake of 8 shares — an estimated $32 sold.

PNC Financial Services Group first reported a position in PDSB in Q2 2018 and held it in 12 quarters. The position peaked at $8K in Q4 2021. 77 funds tracked by Wall St. Rank hold PDSB as of Q2 2024.

  • PNC Financial Services Group reported no remaining PDS Biotechnology position as of Q2 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 8 PDS Biotechnology shares in Q2 2024, an estimated $32.
  • PNC Financial Services Group first reported a position in PDS Biotechnology in Q2 2018 and held it in 12 quarters.
  • PNC Financial Services Group's PDS Biotechnology position peaked at $8K in Q4 2021.
  • 77 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2024.

Based on PNC Financial Services Group's 13F filing for Q2 2024, filed 9 Aug 2024.